Substance Admin Substitution - HL7 Terminology (THO) v6.1.0

HL7 Terminology (THO)
6.1.0 - Publication International flag

This page is part of the HL7 Terminology (v6.1.0: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

CodeSystem: Substance Admin Substitution

Official URL: http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution		Version: 3.0.0
Active as of 2019-03-20	Responsible: Health Level Seven International	Computable Name: SubstanceAdminSubstitution
Other Identifiers: OID:2.16.840.1.113883.5.1070
Copyright/Legal: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html

Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.

This Code system is referenced in the content logical definition of the following value sets:

Generated Narrative: CodeSystem v3-substanceAdminSubstitution

Language: en

Properties

This code system defines the following properties for its concepts

Name

Code

URI

Type

Description

Specializes

Coding

The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.

Generalizes

Coding

Inverse of Specializes. Only included as a derived relationship.

internalId

http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id

code

The internal identifier for the concept in the HL7 Access database repository.

Not Selectable

notSelectable

http://hl7.org/fhir/concept-properties#notSelectable

boolean

Indicates that the code is abstract - only intended to be used as a selector for other concepts

Status

status

http://hl7.org/fhir/concept-properties#status

code

Designation of a concept's state. Normally is not populated unless the state is retired.

Concepts

This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution defines the following codes in a Is-A hierarchy:

Lvl	Code	Display	Definition	internalId	Not Selectable	Status
1	_ActSubstanceAdminSubstitutionCode	ActSubstanceAdminSubstitutionCode	Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.	21284	true	active
2	E	equivalent	Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.	23107		active
3	EC	equivalent composition	Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril	23108		active
4	BC	brand composition	Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven	23109		active
4	G	generic composition	Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)	16623		active
3	TE	therapeutic alternative	Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet	16624		active
4	TB	therapeutic brand	Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics Examples: Zantac for Tagamet	23105		active
4	TG	therapeutic generic	Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands Examples: Ranitidine for cimetidine	23106		active
2	F	formulary	This substitution was performed or is permitted based on formulary guidelines.	16625		active
2	N	none	No substitution occurred or is permitted.	16622		active